Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Azilect (rasagiline) Treatment Report
What is Azilect?

Azilect is a brand name for the drug Rasagiline, a MAO inhibitor which can enhance the activity of dopamine at the synapse. It is sometimes used in early Parkinson's as a monotherapy to enhance naturally existing levels of dopamine, or may be added on as an "adjunct" to other drugs in later stages.

Side Effects

Side effects as an overall problem

Severe
6 5%
Moderate
7 6%
Mild
21 18%
None
80 70%

Most commonly reported side effects

Urinary frequency
13 11%
Anxiety
8 7%
Headaches
6 5%
Difficulty falling asleep (sleep onset insomnia)
5 4%
severe skin rash
4 4%
Nausea
4 4%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Azilect. See all 11 dosages ►

  daily 0.05 mg daily 0.3 mg daily 0.5 mg daily 1 mg daily 1.5 mg daily 2 mg daily 3 mg daily 5 mg daily 6 mg daily 1000 mg daily
  16 Number of Patients: 16 2 Number of Patients: 2 1 Number of Patients: 1 66 Number of Patients: 66 316 Number of Patients: 316 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Azilect (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
28 39% Did not seem to work: 39%
Side effects too severe
28 39% Side effects too severe: 39%
Doctor's advice
18 25% Doctor's advice: 25%
Other
12 17% Other: 17%
Expense
8 11% Expense: 11%
Personal research
7 10% Personal research: 10%
Not indicated
1 1% Not indicated: 1%

See all 70 patients who’ve stopped taking Azilect

Duration See details about how long patients take this treatment ▼

Currently Taking Azilect

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
16
19
61
81
94

Stopped Taking Azilect

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
12
18
13
10
13
5

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
101 89%
Usually
10 9%
Sometimes
1 1%
Never
2 2%

Burden

Difficulty being on treatment

Very
6 5%
Somewhat
9 8%
A little
17 15%
Not at all
82 72%

Cost

Paid out of pocket

$200+
8 7%
$100-199
7 6%
$50-99
11 10%
$25-49
24 21%
< $25
39 34%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.